Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Nutr Diabetes ; 11(1): 12, 2021 04 13.
Article in English | MEDLINE | ID: mdl-33850106

ABSTRACT

Plasma xanthine oxidoreductase (XOR) activity is high in metabolic disorders such as diabetic mellitus, obesity, or overweight. Thus, this study investigated whether the XOR inhibitor, topiroxostat, affected body weight. Male db/db mice were fed standard diets with or without topiroxostat for 4 weeks. Body weight and food intake were constantly monitored, along with monitoring plasma biochemical markers, including insulin and XOR activity. Additionally, hepatic hypoxanthine and XOR activity were also documented. Single regression analysis was performed to determine the mechanism. Topiroxostat treatment suppressed weight gain relative to the vehicle without any impact on food intake. However, the weight of fat pads and hepatic and muscle triglyceride content did not change. Topiroxostat decreased the plasma uric acid and increased hepatic hypoxanthine in response to the inhibition of XOR activity. Plasma ketone body and free fatty acid were also increased. Moreover, fat weight was weakly associated with plasma XOR activity in the diabetic state and was negatively associated with ketone body by topiroxostat. These results suggested that topiroxostat amplified the burning of lipids and the salvage pathway, resulting in predisposing the body toward catabolism. The inhibition of plasma XOR activity may contribute to weight loss.


Subject(s)
Body Weight/drug effects , Diabetes Mellitus, Experimental/drug therapy , Enzyme Inhibitors/pharmacology , Nitriles/pharmacology , Obesity/drug therapy , Pyridines/pharmacology , Xanthine Dehydrogenase/antagonists & inhibitors , Animals , Diabetes Mellitus, Experimental/blood , Fatty Acids, Nonesterified/blood , Humans , Hypoxanthine/analysis , Insulin/blood , Liver/metabolism , Male , Mice , Mice, Obese , Obesity/blood , Triglycerides/analysis , Uric Acid/blood , Weight Gain/drug effects , Xanthine Dehydrogenase/blood
SELECTION OF CITATIONS
SEARCH DETAIL